Story thread · 2 reports / 2 sources
The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone.
investors.com · 3h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Xenon Pharmaceuticals voluntarily halted enrollment in a handful of studies Friday due to several unexpected side effects. The biotech stock crashed to a six-month low. The post The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone. appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.